# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
Alzemend Neuro made waves Tuesday when the company announced its decision to terminate its "at-the-market" equity offer...
Alzamend Neuro, Inc. (NASDAQ:ALZN) ("Alzamend"), a clinical-stage biopharmaceutical company focused on developing novel...
The Dow Jones index closed lower by around 0.1% on Wednesday. When insiders purchase or sell shares, it indicates their confide...
The Dow Jones index closed lower by over 200 points on Monday. When insiders purchase or sell shares, it indicates their confid...